Any sufficiently complex set of biological data assessed in a large population of various ages can be used as a basis to create an aging clock. Machine learning techniques are used to find algorithmic combinations of measurements that map to chronological age or observed mortality risk within the reference population. That algorithm then predicts age or mortality risk when used in people outside the reference population; where a person's predicted age is higher than chronological age this is thought to represent a higher burden of damage and dysfunction, and thus a greater biological age. Aging clocks have been show to work pretty well at a population level, but it remains difficult to establish how the measured parameters are determined by mechanisms of aging, and whether a clock assessment is of any practical use for one individual in the health and medical contexts.
Nonetheless, researchers are creating new clocks at a fair pace. Most omics based clocks use immune cells from a blood sample, and there has been some discussion over the years as to how relevant this is to aging in other tissues. Another point of interest has been how to separate variations in immune function that arise from stress, infection, and other transient causes from those arising from mechanisms of aging. With this background context in mind, today's open access paper reports on the use of a single cell assessment of chromatin accessibility in many different immune cell subtypes. Chromatin is structured nuclear DNA, with different sections either spooled and compact to prevent gene expression, or unspooled and accessible for gene expression. This structure is controlled by epigenetic decorations, and determines the behavior of the cell by determining which proteins are manufactured.
The aging process in humans constitutes a complex progression that exerts widespread effects across various organ systems, with the immune system displaying particularly significant dysregulation. This deterioration of immune integrity, often termed immunosenescence, is intrinsically linked to an attenuated capacity for tissue regeneration, a heightened vulnerability to infectious diseases, and the disruption of systemic homeostasis, all of which facilitate the pathogenesis of age-associated morbidities. While chronological age serves as a rough proxy for these changes, it often fails to capture the substantial heterogeneity in health trajectories among individuals. Consequently, the quantification of biological age through molecular biomarkers has emerged as a pivotal strategy to assess aging status and predict health outcomes. Among the hallmarks of aging, epigenetic remodeling is considered a primary driver of the aging process.
The concept of an epigenetic clock was pioneered using DNA methylation data. However, the majority of existing DNA methylation clocks rely on bulk tissue profiles, which makes it difficult to discern whether observed changes arise from alterations within specific cells. Chromatin accessibility, measured by single-cell assay for transposase-accessible chromatin-sequencing (scATAC-seq), reflects the regulatory potential of the genome. As an upstream layer, chromatin state provides unique mechanistic insights into how the aging process rewires the regulatory network of immune cells, yet high-resolution clocks based on scATAC-seq remain unexplored.
To decode the epigenetic heterogeneity of immune aging, the cell-type-specific chromatin accessibilityaging clock sc-ChromAging were constructed using a high-quality scATAC-seq dataset derived fromthe Chinese Immune Multi-Omics Atlas (CIMA) cohort. The predictive performance of sc-ChromAging was evaluated across five major immune cell types. Significant heterogeneity in predictive performance was observed, and the CD4+ T cells exhibited the highest predictive accuracy. To further investigate the epigenetic signatures of aging at higher granularity, the analysis was extended to 25 immune cell subtypes. Consistent with the lineage-level findings, subtypes within the T cells displayed higher predictive accuracy. Notably, CD4+ naïve T cells showed the highest accuracy among subtypes.
The relatively high predictive accuracy observed in CD4+ naïve T cells suggested that their chromatin landscape may effectively reflect the biological aging process. Mechanistically, this high precision may be related to the intrinsic program of thymic involution. Unlike memory or effector subsets whose epigenomes are mainly remodeled by antigen exposure, naïve T cells may maintain a relatively quiescent state where chromatin accessibility changes are driven primarily by the intrinsic aging program. Notably, although CD8+ naïve T cells also showed relatively good predictive performance, their accuracy remained lower than that of CD4+ naïve T cells. This distinction suggests that a quiescent phenotype alone does not necessarily confer the same degree of age predictability across naïve T-cell compartments. One possible explanation is that the chromatin state of CD8+ naïve T cells may be more susceptible to extrinsic regulatory influences associated with their survival and maintenance, including cytokine-dependent homeostatic signals and other environmental stimuli.
View the full article at FightAging
